UNSPSC 51191944: Thiamine monochloride

This classification denotes a b vitamin with the molecular formula C12H17N4OS.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X66NSO3N35, chemically known as thiazolium, 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methyl- chloride (1:1), but more generally known as thiamine monochloride, which bears US NIH Compound Identifier 6042. European Medicines Agency schedules thiamine monochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10969MIG.

Most nations, for tariff purposes, schedule thiamine monochloride under HS 29362200. SMILES: CC1C(SC[N+]1CC2CNC(NC2N)C)CCO.[CL-].

UNSPSC 51191944 Thiamine monochloride is a Commodity code that encompasses chemical supply to state and local government facilities, particularly water treatment, wastewater management, and pharmaceutical distribution operations. State and local buyers under this code source bulk chemical commodities and pharmaceutical products for operational and clinical use. The issuing bodies include municipal water utilities, state cooperative purchasing alliances administering multi-jurisdictional pharmaceutical procurement, and subordinate government facilities across participating states. The scope reflects commodities procured on a unit-cost or per-unit basis, with detailed product specifications, quality certifications, and supply-chain security requirements driving vendor selection.

Recent activity shows the City of Meriden, Connecticut posting an IFB for sodium bisulfite chemical supply (B027-15, due July 29, 2026) for its Water Pollution Control Facility under similar commodity-procurement principles. More broadly, the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota, Oregon, and other member jurisdictions. The MMCAP procurement required vendors to certify cGMP and Drug Supply Chain Security Act compliance, maintain authorized-wholesaler relationships, and accept a 3 percent administrative fee structure, with contract effectiveness set for July 1, 2026. Both opportunities signal active municipal and regional cooperative purchasing in chemical and pharmaceutical commodities where bidders must meet insurance, compliance, and bonding requirements prior to contract execution.